Design and Evaluation of The Floating Oral In Situ Gelling System of Levofloxacin Hemihydrate to Dysphagia Patients
Abstract
Pediatric, geriatric, and dysphagia patients often experience difficulty swallowing solid preparations and discomfort when administered by injection. Levofloxacin is marketed as available in tablet and injection forms, such as in Indonesia. This study aims to develop an aqueous dispersion formulation for a floating oral gelling system of levofloxacin hemihydrate with sustained release delivery. HPMC and sodium alginate were combined as polymers to form an in situ gel system in an acidic environment. The optimization was performed based on the simplex lattice mixture design method. The effect of variations in the concentration of both polymers influenced the viscosity of the formula. The optimum formula was 0.378% sodium alginate and 0.122% HPMC. The drug release mechanism of the optimum formula followed the Korsmeyer-Peppas model. The kinetic mechanism of drug release fits into 2-compartment. The developed formulation offers augmented gastric retention of levofloxacin hemihydrate, leading to improved efficacy.
Read the paper
Related studies
- Ferulic acid regulates the AKT/GSK-3β/CRMP-2 signaling pathway in a middle cerebral artery occlusion animal model
- Novel Pharmacokinetic/Pharmacodynamic Parameters Quantify the Exposure–Effect Relationship of Levofloxacin against Fluoroquinolone-Resistant Escherichia coli
- Photochemical behavior of levofloxacin
- Correlation Between Dissolution Profiles of Salt-Form Drugs in Biorelevant Bicarbonate Buffer and Oral Drug Absorption: Importance of Dose/ Fluid Volume Ratio
- Evaluation of the synergistic potential and mechanisms of action for de novo designed cationic antimicrobial peptides
- Synthesis of [11C]levofloxacin
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.